BALTIMORE, MD—August 28, 2014—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the availability of a compelling CME-certified Webcast, Medical Insiders: An In-Depth Discussion on Emerging Therapies in the Management of Advanced Gastric and Esophagogastric Junction Adenocarcinomas.

Upper gastrointestinal cancers, specifically esophagus and stomach cancers, account for a considerable portion of the cancer burden in the United States. Gastric and esophagogastric junction (EGJ) adenocarcinomas compose 95% of the total number of malignancies and are often associated with poor prognoses. Targeted therapy can be an ideal approach to the treatment of gastric and EGJ adenocarcinomas due to its proven benefit in other disease states, the limited efficacy of chemotherapy, and the lack of overlap toxicity between targeted agents and chemotherapy. With an increase in the number of clinical trials focusing on molecular targeted therapies alone and in combination with various chemotherapeutic agents, Med-IQ has sponsored this educational activity to help oncologists stay abreast of clinical advances in this evolving field.

“In this roundtable Webcast, my colleagues and I discuss current challenges in the management of advanced gastric and EGJ adenocarcinomas and make recommendations for best practices based on clinical trials and personal experience,” said Charles S. Fuchs, MD, MPH, professor of medicine at the Harvard Medical School in Boston, MA. “We also examine the clinical rationale behind the development of novel targeted agents, review key molecular pathways, and explore strategies for incorporating recent therapeutic advances into patient care.”

		Peter C. Enzinger, MD Assistant Professor of Medicine Harvard Medical School Director, Center for Esophageal and Gastric Cancer Dana-Farber Cancer Institute Boston, MA
		Charles S. Fuchs, MD, MPH Professor of Medicine Harvard Medical School Chief, Division of Gastrointestinal Oncology Director, Center of Gastrointestinal Cancer Dana-Farber Cancer Institute Boston, MA
		David H. Ilson, MD, PhD Professor of Medicine Weill Medical College, Cornell University Memorial Sloan Kettering Cancer Center New York, NY

Oncologists are invited to visit www.Med-IQ.com/a802 for complimentary access to this educational activity. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com.

Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit lillygrantoffice.com.

About Med-IQ

Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management to improve team performance and patient outcomes. These initiatives have achieved improvements in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training has been published 27 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.


For more information, contact:

Amy Caswell
Senior Audience Development Manager
Med-IQ
866 858 7434
info@med-iq.com